Medications During Pregnancy

Why Pregnancy Changes Everything

Pregnancy is one of the most profound physiological states a human body can experience. Nearly every organ system changes — blood volume expands by 40–50%, kidney filtration speeds up, liver enzyme activity shifts, stomach emptying slows, and body fat increases. Each of these changes affects how medications are absorbed, distributed, broken down, and eliminated. A dose that works perfectly in a non-pregnant adult may be too high or too low for the same person during pregnancy.

At the same time, pregnancy introduces a second consideration that does not exist in most other medical situations: the developing baby. Every decision about medication use during pregnancy involves weighing the potential benefit to the mother against the potential risk to the fetus. That balance is rarely simple, and it changes week by week as the baby develops.

This guide is designed to help you understand the framework that doctors, pharmacists, and researchers use to think about medication safety in pregnancy — so you can have informed conversations and make better decisions alongside your healthcare team.

How Drugs Reach the Baby

The placenta is not an impenetrable barrier. Most small-molecule drugs pass through the placenta to some extent via passive diffusion, the same physical process that allows oxygen and nutrients to cross. A drug's ability to cross depends on several factors:

• Molecular size: Smaller molecules cross more easily.
• Lipid solubility: Fat-soluble drugs cross more readily than water-soluble ones.
• Protein bindingProtein Binding

  The reversible binding of drugs to plasma proteins (primarily albumin). Only the unbound (free) fraction of a drug is pharmacologically active. Highly protein-bound drugs can be displaced by other dru

  : Drugs that are tightly bound to proteins in the mother's blood cross less freely.
• Ionization: Unionized (neutral) forms of drugs cross more easily than ionized forms.

Once a drug reaches fetal circulation, the fetus processes it differently than an adult would. Fetal liver enzymes are immature, so many drugs are metabolized more slowly. Drug metabolites can accumulate in fetal tissue. The fetal kidneys excrete drugs into amniotic fluid, which the fetus then swallows — creating a recycling loop that can prolong fetal exposure.

The FDA Pregnancy CategoryFDA Pregnancy Category

A classification system (Categories A, B, C, D, X) that was used to indicate the risk of drug use during pregnancy. In 2015, the FDA replaced this system with the Pregnancy and Lactation Labeling Rule

System

For decades, the FDA used a letter-based system to summarize pregnancy safety data for drugs. You may still see these letters on older packaging or in older references:

Category C was by far the most common — covering drugs where human data was simply absent, not necessarily dangerous. This created significant confusion, because a drug with no data at all received the same letter as a drug with concerning animal data.

The Newer Pregnancy and Lactation Labeling Rule

In 2015, the FDA replaced the letter categories with the Pregnancy and Lactation Labeling Rule (PLLR) for all new drugs and biologics. Instead of a single letter, labeling now includes three narrative subsections:

1. Pregnancy — summarizes human and animal data, discusses dosing considerations, and describes a pregnancy exposure registry if one exists.
2. Lactation — covers data on drug passage into breast milk and effects on the nursing infant.
3. Females and Males of Reproductive Potential — addresses contraception requirements and fertility effects.

This system provides more nuanced information, but it also means you need to read a paragraph rather than a single letter. Many older drugs still carry the legacy letter categories until their labeling is updated.

Trimesters and Risk Windows

Timing matters enormously when evaluating medication risk during pregnancy.

First Trimester: Organ Formation

The first trimester — roughly weeks 1 through 13 — is when the embryo's major organ systems form. This is called organogenesis, and it is the period of highest risk for structural birth defects (teratogenesis). A drug that disrupts organ formation during this window can cause permanent abnormalities. The neural tube (brain and spinal cord) closes around days 21–28 — often before a woman even knows she is pregnant. This is why folic acid supplementation is recommended starting before conception.

Second and Third Trimester Risks

After the first trimester, the risk of major structural defects decreases because organ formation is largely complete. However, drugs can still affect fetal growth, brain development, and organ maturation. Some medications taken near delivery can cause withdrawal symptoms or breathing difficulties in the newborn. For example, benzodiazepines and opioids taken in late pregnancy can cause neonatal abstinence syndrome.

Commonly Used Medications and Pregnancy Safety

Here is a brief overview of common medication categories and what is generally known about their pregnancy safety:

Pain relievers: Acetaminophen (paracetamol) has the longest track record of use in pregnancy and is generally considered the first-choice pain reliever. NSAIDs (ibuprofen, naproxen) are typically avoided after 20 weeks because they can reduce amniotic fluid and affect fetal kidney development. Aspirin in low doses is sometimes specifically prescribed during pregnancy to reduce the risk of preeclampsia.

Antibiotics: Many antibiotics are used safely in pregnancy. Penicillins and cephalosporins have extensive safety records. Tetracyclines are avoided because they can affect fetal bone and tooth development. Fluoroquinolones are generally avoided due to concerns about cartilage development.

Antidepressants: This is a nuanced area. SSRIs are among the most studied antidepressants in pregnancy. Some studies have raised concerns about certain cardiac malformations with first-trimester paroxetine use. Neonatal adaptation syndrome — temporary symptoms in the newborn — has been reported with late-pregnancy SSRI use. However, untreated severe depression or anxiety also carries real risks for both mother and baby.

Anticoagulants: Warfarin crosses the placenta and can cause a specific pattern of birth defects. Low-molecular-weight heparins (like enoxaparin) do not cross the placenta and are preferred for anticoagulation during pregnancy. The newer direct oral anticoagulants (DOACs) are generally avoided due to limited safety data.

Antiepileptics: This category requires careful individual assessment. Some antiepileptic drugs carry substantial teratogenic risk, but uncontrolled seizures during pregnancy also carry serious risks. Decisions should always be made with a specialist.

When Untreated Illness Is the Bigger Risk

One of the most important — and most often overlooked — points about medications in pregnancy is that the disease being treated also carries risks. Stopping a medication without medical guidance can be just as dangerous as continuing it.

Consider a pregnant woman with well-controlled epilepsy. If she stops her antiepileptic medication out of fear of fetal harm, she may experience seizures that could cause falls, oxygen deprivation, and serious consequences for both her and her baby. Similarly, undertreated severe depression or anxiety can affect a mother's ability to eat well, attend prenatal appointments, and bond with her baby after birth.

The question is never simply "is this drug safe?" The question is "do the benefits of treating this condition outweigh the risks of the medication?" That calculation is different for every person, every condition, and every drug.

How to Have the Conversation With Your Provider

When you need to discuss a medication during pregnancy, come prepared:

• List all medications, including over-the-counterOver-the-Counter

  Medications that can be purchased without a prescription, deemed safe for consumer use when following the label directions. The FDA determines OTC status based on a drug's safety profile, abuse potent

  drugs, vitamins, and herbal supplements. Many people forget to mention things like antacids, antihistamines, or melatonin, which are also relevant.
• Ask specifically about timing: Is the risk different in the first trimester versus later? Is there a safer alternative with more pregnancy data?
• Ask about registries: Many drug manufacturers and academic centers operate pregnancy exposure registries that collect outcomes data. Enrolling can contribute to knowledge that helps future patients.
• Do not stop prescribed medication without talking to your provider first. Abrupt discontinuation of some drugs — antidepressants, antiepileptics, blood pressure medications — can cause serious problems.
• Use evidence-based resources: The FDA's drug labeling, LactMed (for breastfeeding), and MotherToBaby (a nonprofit teratogen information service) are reliable starting points.

Key Takeaways

• Pregnancy alters how the body processes drugs, affecting dosing and drug levels.
• Most drugs cross the placenta to some degree; the extent depends on molecular size, fat solubility, and protein binding.
• The FDA replaced letter pregnancy categories with narrative labeling (PLLR) in 2015; older drugs may still carry legacy letters.
• The first trimester carries the highest risk for structural birth defects; second and third trimester exposures carry different risks.
• Untreated illness during pregnancy can also harm the fetus — the question is always about balancing risks and benefits.
• Never stop a prescribed medication during pregnancy without medical guidance.
• Use reputable resources like MotherToBaby, LactMed, and FDA labeling when researching medication safety in pregnancy.